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The  T  cell  recognizes  and  responds  to  non-major  histocompatibility  complex 
(MHC) 1 antigens  only when  presented  in  some  association  with  the  polymorphic 
allele specific determinants ofself-MHC. The cytotoxic response is restricted to allele- 
specific determinants  encoded by class  I  MHC  loci  (1)  and  the  helper  response  is 
restricted to those encoded by class II (2). 
A high frequency of T  cells  responds to allogeneic MHC. These responses against 
allogeneic MHC are largely directed against the same allele-specific determinants and 
show the same bias toward an association between killer function and class I  MHC 
determinants and helper function and class II (3). 
T  cell subsets can also be defined by cell surface molecules, the Lyt antigens in the 
mouse  (4),  and  the  Leu  antigens  in  the  human  (5).  T  cells  that  recognize class  I 
antigens display Lyt-2 (6) in the mouse or Leu-2 in the human (7) and their function 
is blocked by these reagents  (8-10),  T  cells  that recognize class II determinants  are 
Lyt-2 negative or low (6) or in the human are Leu-2a negative, Leu-3a positive (7,  11, 
12). 
The correlation between T  cell function and MHC class takes the form of a  bias 
and is not absolute. The correlation between surface antigen phenotype and MHC 
class recognized may be absolute (6,  12). 
The similarities in the characteristics of the T  cells  that respond to self-MHC plus 
nominal antigen X  and to allogeneic MHC  are striking.  In the allogeneic response 
one would expect T  cells  that would respond to the nonpolymorphic parts of MHC 
molecules to be missing because of self-tolerance. The restriction to the polymorphic 
determinants  in  the  response  to  self plus  X  requires  some other explanation.  The 
association  between  cell  surface  molecules  (revealed  by anti-Lyt  and  anti-Leu  re- 
agents)  and  the  class  of MHC  antigen  presented  in  both  the  self plus  X  and  the 
allogeneic response might be taken to suggest some features of a cell interaction that 
can take place equally well between syngeneic and allogeneic cells. 
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We have therefore examined these same features, specificity for common or poly- 
morphic epitopes, associations of function  with  MHC  subregion,  and expression of 
Leu differentiation markers with function, in a  xenogeneic response, that of human 
peripheral blood T  cells responding against mouse T-depleted spleen cell populations. 
We  could  find  no  significant  differences  in  the  characteristics  of the  xenogeneic 
compared with the allogeneic response in any of the features examined. 
On the basis of these results we propose that  there are two components to T  cell 
recognition of MHC  antigen. One component  is an interaction with an area on the 
molecule that does not carry the polymorphic determinants and which is conserved 
between species. This is the interaction that distinguishes between class I and class II 
MHC  molecules. The other component  is the recognition of the polymorphic deter- 
minants of the MHC  molecule. It is important to note that these two components do 
not correspond to the two recognition events that  figure in the classic one receptor/ 
two receptor debate. In our model, the first component is a  separate recognition step 
not previously considered and it is the second component, that which recognizes the 
polymorphic  part  of  MHC,  be  it  syngeneic,  allogeneic,  or  xenogeneic,  that  may 
involve one or two receptors in the traditional sense. The model that we propose does 
not address this issue. 
Materials  and  Methods 
Mice.  All strains of inbred mice were bred in our colony at the University of California at 
San Diego. Original breeding pairs were obtained from The Jackson Laboratory, Bar Harbor, 
ME, and from Dr.  Donald Shreffler (Washington University School of Medicine, St.  Louis, 
MO). 
Human Peripheral Blood Lymphocytes (PBL).  Responder cells were  obtained  from  healthy 
volunteers and purified by Ficoll-Hypaque flotation (13). 
Mouse Stimulator Cells.  These were from pooled spleen cells. Spleen cells were treated with 
two monoclonal anti-Thy-  1.2 reagents (F7D5 of P. Lake and HO- 13.4 of Marshak-Rothstein). 
Resulting non-T cells were mitomycin treated and used as stimulators. 
Xenogeneic Cultures.  Primary cultures were set up with 10  7 human PBL plus 3-4 ×  107 mouse 
stimulators in a total volume of 20 ml RPMI supplemented with 5% selected fetal calf serum, 
penicillin (100  U/ml), streptomycin (100  #g/ml);  L-glutamine (2 mM), and  5  x  10  -5 M  2- 
mercaptoethanol. Twice during the first 7-10 d of culture, 25% of the medium was replaced. 
Cell-mediated Lympholysis.  Primary cultures were harvested after 8-10 d and passed through 
nylon  columns.  Recovered  T  cells were  cultured  in  Linbro  wells  (Linbro  Chemical  Co., 
Hamden, CT) in a total volume of 2 ml at 1 ×  106/ml with mouse stimulators prepared as for 
primary culture at 3 X  106/ml. After 4 d cells were harvested and cytotoxicity was determined 
on  mouse  splenic 51ehromium-51-1abeled  (Cr  51)  concanavalin  A  (Con  A)  (2  mg/ml)  plus 
lipopolysaceharide (LPS) (10 #g/ml)-induced blast targets. 
Production of Interleukin 2 (IL-2).  Primary human anti-mouse cultures were harvested after 
10  d  and  cells were  passed through  nylon  wool  (see  section above).  Effluent  T  cells were 
untreated or treated with mitomycin. Human T  cells at 5 X  105/ml were mixed with mouse 
stimulators at 2-3 X  106/ml in 1-ml Linbro cultures. Culture supernatants were collected after 
24 h and tested for IL-2 activity by their ability to support the growth of an IL-2-dependent 
NK line (14)  and by their ability to co-stimulate the Con A-induced proliferation of murine 
thymocytes (14). Similar results were obtained in both assays. 
Blocking with Anti-Leu-2a  and Anti-Leu-3a  Reagents.  Monoclonal antibodies to Leu-2a and 
Leu-3a (5, 8) were obtained from Becton, Dickinson & Co., Oxnard, CA. These reagents were 
added directly to the assays of cytotoxic effects and to the cultures for the production of IL-2. 
These reagents were present at --<5% final concentration corresponding to an antibody concen- 
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Results 
Specificity of the  Cytotoxicity Response.  Human  PBL  were  cultured  for  7  d  with 
mitomycin  C-treated,  T-depleted  mouse spleen  cells  as  described  in  Materials  and 
Methods. The human cells were harvested, washed, and resuspended in fresh medium. 
They  were  restimulated  with  mouse stimulator  cells  that  were  syngeneic  with  the 
initial stimulators, syngeneic at K and D only, syngeneic at I only, or totally allogeneic. 
The cells were harvested after another 4 d and assayed on 5aCr-labeled targets which 
were  syngeneic  with  the  stimulator  cells  used  in  the  second  culture  period.  This 
experimental protocol was thus designed to assay the specificity of responder T  cells 
that were restimulatable in the second culture. 
As  can  be  seen  from  Fig.  1,  a  strong cytotoxic response  was  obtained  when  the 
secondary  stimulator  cells  were  syngeneic  with  the  stimulators  used  in  the  initial 
culture.  In the experiment shown, an equally good cytotoxic response was also seen 
when the secondary stimulators [B 10.T(6R)] shared only the K and D  alleles with the 
primary stimulators. In contrast, no measurable response was obtained with allogeneic 
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FIG.  1.  Specificity of restimulation of human anti-mouse response. Human PBL were stimulated 
in vitro with mitomycin-treated non-T cells from the spleens of B10.AQR mice. After 10 d, cultures 
were harvested, nylon wool passed, and restimulated with non-T cells from B10.AQR (0); B10.BR 
(&);  B10.T(6R)  (A); or B10. (O)  mice. Cytotoxicity on homologous SlCr-labeled mouse targets was 
determined after 4 d of culture. The MHC haplotype of mouse strains at K.IA.IE/C.D  are shown. 
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FIG.  2.  Target  specificity  of secondary  human  anti-mouse CTL  effectors.  Human  PBL  were 
primed and restimulated in vitro with B 10.A(3R) non-T cells. Cytotoxic effectors were measured on 
a  panel of mouse targets: B10.A(3R)  (O), B6 (O), B6.C.H-2  ha J),  BI0.A(2R)  ([Z]), and B10.A(4R) 
(A). SWAIN, DUTTON,  SCHWAB,  AND  YAMAMOTO  723 
(B10)  cells  as  secondary stimulators,  whereas  only a  small  response was seen  with 
B10.BR  cells that  share I  region alleles. This basic pattern of results was seen in  a 
series of experiments using PBL from five different human donors.  In most cases it 
was  an  advantage  to  have  the  same  I  region  as  well  as  the  same  K/D  in  the 
restimulation  (not shown).  In some experiments stimulators differed at background 
(for instance, B10 vs. A backgrounds) and this did not affect the degree of cytotoxicity 
elicited (not shown). 
The specificity of the cytotoxic T  lymphocyte (CTL) effectors was investigated in 
a second experimental protocol in which human CTL were generated by stimulation 
and restimulation with the same mouse haplotype, B 10.A(3R). These were assayed on 
a  series  of 51Cr-labeled  targets  (Fig.  2).  B10.A(3R)  targets  were  killed  efficiently, 
whereas allogeneic targets [B10.A(4R)]  were not lysed. A  trace amount of lysis was 
seen on a IE/C region-compatible target [B 10.A(2R)].  B6, which shares K b and IA  b, 
was lysed at an intermediate level. Targets from the B6.C.H-2  b" (bin-l) mutant were 
lysed slightly less than  the wild-type B6.  This latter result,  seen in  four out  of five 
experiments,  suggested  that  a  portion  of  the  human  CTL  raised  against  K b 
[B10.A(3R)] killed K b (B6)  better than K b" (B6.C.H-2ba). 
Specificity  of the Induction of IL-2 Production.  Although  CTL effectors were specific 
for K  or D  alloantigens,  human  PBL were also able to respond  to mouse I  region 
antigens  in  an  allele-specific manner  and  produce  IL-2.  In  these  experiments  the 
production  of IL-2 was measured  during  a  24-h  culture  period  when  human  PBL 
were restimulated with mouse T  cell-depleted spleen cells syngeneic or allogeneic to 
the original stimulator mouse cells. The human IL-2 was assayed by the proliferation 
of an IL-2-dependent mouse NK cell line. 
In Fig. 3 it can be seen that significant IL-2 production was seen when B 10.A(3R)- 
primed cells were restimulated with cells syngeneic at IA, that is cells from B 10.A(3R), 
B6, and B6.C.H-2  ha. No IL-2 production was seen when cells used as stimulators were 
compatible only at D  (B10.A)  or were totally allogeneic [B 10.A(4R)]. It is important 
to  note that  this  result  confirms the expectation  that  the  IL-2 is  produced  by the 
human lymphocytes rather than the T-depleted mouse cells used as stimulators in the 
second culture. Similar results were seen in a series of experiments involving cells from 
four human donors and various combinations of mouse stimulators from H-2-recom- 
binant  strains, including  B10.AQR-stimulated  cells, which were successfully restim- 
CPM/Culture 
Stimulator  200  400  1000 
None 
B10.A 3R bbdd 
B6 bbbb 
B6.H2  ba ba_bbb 
B10.A kkdd 
B10.A 4R kkbb 
FIG.  3.  Specificity of restimulation of IL-~ production. Human PBL were primed in vitro with 
B 10.A(3R).  After 7 d, cultures were harvested, nylon wool passed, and restirnulated with a panel of 
mouse non-T stimulators. Supernatants were harvested from triplicate cultures after 24 h and added 
at 15% final volume to an IL-2 assay. The background proliferation in the IL-2 assay without added 
factors was 189 cpm per culture. 724  XENOGENEIC  HUMAN ANTI-MOUSE T  CELL  RESPONSES 
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Fro. 4.  Anti-Leu-2a and anti-Leu-3a effects on cytotoxic killing.  Human PBL were primed and 
restimulated in vitro with B 10.A(3R) cells. Monoclonal anti-Leu-2a was added at a top concentra- 
tion of 2.5% (1/~g/ml) and at a  1:3 dilution, and anti-Leu-3a was added at 2.5% (1/.tg/ml) during 
the 4-hour assay. Targets were B10.A(3R)  51Cr-labeled blast  cells induced by Con A and LPS. A 
titration of cytotoxic effectors was tested  for these conditions.  Only the effect at an effector/target 
ratio of 50:1 is shown. The same pattern of blocking was seen at  17:1 and 6:1. 
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FIo.  5.  Anti-Leu-2a and anti-Leu-3a effects on IL-2 production.  Human PBL were primed and 
restimulated in vitro with B10.A(3R)  cells. Monoclonal anti-Leu-2a at  1% (0.4/~g/ml) and anti- 
Leu-3a at  1% (0.4/Lg/ml)  and 0.33% (1:3) were added to triplicate cultures during the generation 
of IL-2. IL-2 production was determined as in Fig. 4. 
ulated with B10.AQR  or B10.BR  but not with B10.T(6R),  and B10.AQR-stimulated 
cells, which produced IL-2 after restimulation with A.TL but not A.TH  or B 10.T(6R). 
Specificity of Blocking with Anti-Leu Reagents.  Anti-Leu  reagents  were  tested  for the 
blocking of the response of human  lymphocytes  to mouse MHC  antigens. 
The  CTL Response.  In  this  protocol  anti-Leu-2a  or  Leu-3a  reagents  were  present 
only during  the CTL  assay.  It  can  be seen  in  Fig.  4  (which  is  representative  of five 
similar experiments  with different strain  combinations)  that  CTL  effectors raised  by 
primary  stimulation  with  B 10.A(3R)  restimulated  with  B10.A(3R)  were blocked  by 
the presence of anti-Leu-2a  but  not by anti-Leu-3a. 
IL-2  Production.  The  same  reagents  had  the  opposite  effect  in  blocking  IL-2 
production  (Fig.  5).  Thus  the  anti-Leu-2a  that  had  markedly  inhibited  the  CTL 
response  to  K  and  D  antigens  had  no  effect  on  the  production  of IL-2  to  I  region 
antigens.  The  anti-Leu-3a  that  had  no  effect on  CTL  activity  (Fig.  4)  now  blocked 
IL-2  production  in  response  to  I  region  antigens.  In  these  experiments  human  cells 
stimulated  with  B10.A(3R)  in  the  first  culture  were  restimulated  with  B10.A(3R) 
(upper panel) with B6.C.H-2 b" (lower panel). The anti-Leu reagents were present only SWAIN, DUTTON, SCHWAB, AND YAMAMOTO  725 
in  the  second culture  period.  Anti-Leu  reagents  added  to the  assay of IL-2 at  the 
concentrations  found  in  these  supernatants  had  no effect on  proliferation.  Similar 
results were seen in a series of experiments using PBL from several donors. 
Discussion 
The results presented here show:  (a)  That human T  cells respond strongly to the 
mouse MHC antigens.  (b)  That  the response is predominantly to the allele-specific 
determinants.  (c)  That  the bias in  the association between  T  cell  function  and  the 
class of MHC molecule that is recognized operates across species. CTL are generated 
to  xenogeneic  class  I  antigens  and  IL-2  producers  to  xenogeneic  class  II-encoded 
determinants.  (d)  That the cytotoxic response to xenogeneic class I MHC antigens is 
blocked by anti-Leu-2a and the response of IL-2-producing cells to xenogeneic class 
II antigen is blocked by anti-Leu-3a. 
The first and second observations confirm the earlier studies of Lindahl and Bach 
(15,  16). There is little or no response to the non-MHC antigens of the mouse or to the 
nonpolymorphic determinants of the mouse MHC. This is in marked contrast to most 
MHC-specific antibodies raised across species. Many of these antibodies are broadly 
polymorphic or monomorphic with only a few being allele specific. Cross-reactions on 
species not closely related are rare (17). 
The size of the in vitro T  cell response suggests that the frequency of the T  cells 
that recognize the mouse allele-specific determinants is closer to that of T  cells that 
recognize allele-specific determinants within  the species than to that of T  cells that 
recognize non-MHC antigens. 
The killing of mouse targets cells in the CTL assays strongly argues that the human 
CTL effectors are able to recognize and use the mouse MHC  molecules instead  of 
human  MHC  molecules because  the  possibility of representation  of mouse  MHC 
determinants in conjunction with human MHC is minimized under these conditions. 
These observations, surprising  in  themselves, are made more remarkable by the 
finding that the T  cell makes the same "functional" distinction  between class I and 
class II antigen as is seen within the species. First, the T  cells that recognize xenogeneie 
class I antigen are or become T  killers (Fig.  1), and second, their function is blocked 
by anti-Leu-2a (the human counterpart of the mouse Lyt-2) (Fig. 4). Conversely, the 
T  cells that recognize xenogeneic class II antigen  are or become committed to IL-2 
production  (Fig. 2) and their induction  is blocked by anti-Leu-3a (the marker found 
on the human helper T  cell subpopulation)  (Fig. 5). This shows the same correlation 
of blocking specificity and  class specificity that  has been seen  in  the  human  anti- 
human response (7,  10-12). 
What  can  one  conclude  from these  observations?  The  salient  features  of T  cell 
recognition  of antigen  have been  apparent  for a  number of years.  These  features, 
which are not predicted by a simple model based on antibody specificity, have led to 
a number of hypotheses for the structure of the T  cell receptor or receptors but remain 
to be satisfactorily explained. They are listed here in a  form that will be relevant to 
our subsequent discussion. 
(a)  All  T  cells  recognize  MHC  (the  fact  that  there  may  be  some  T  ceils  that 
recognize free antigen does not undermine the significance of this as one can assume 
that they may do so by an alternative mechanism). 
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reactions to a nominal antigen X rarely, if ever, show cross-reactivity to X plus other 
MHC alleles (18). Thus, the polymorphic parts of the molecule seem most significant. 
Second,  there  is  a  recognition  of class  I  MHC  as  distinct  from  class  II.  This  is 
demonstrated by the fact that separate populations of cells (distinguishable by Lyt or 
Leu  blocking experiments)  recognize  class  I  or class  II MHC  gene  products.  This 
recognition works across species (this paper). 
(c) There is a  strong bias (not absolute) associating the class I, Lyt-2  + subset with 
killing and the class II, Lyt-2- subset with helper function. 
(d)  T  cells that recognize a  self-allele of MHC plus non-MHC antigen, X, have a 
high frequency of cross-reaction on foreign MHC alleles (19, 20). 
We feel that the features listed in b above are best explained conceptually by two 
levels of recognition. In the first level of recognition, the T  cell receptor must engage 
with an MHC molecule. It seems likely that the distinction between class I and class 
II is made here. The data presented in this paper suggest that the parts of the MHC 
molecule involved in this recognition  are nonpolymorphic and must be sufficiently 
conserved so that the human T  cell can effectively identify the mouse class I and class 
II components. 
In the second level of recognition the T cell receptor must recognize the polymorphic 
part of the MHCI molecule, The data presented here and those previously reported by 
Lindahl  and  Bach  (15,  16)  show  that  the  capacity  to  recognize  mouse  alleles  is 
contained within the human T  cell repertoire. 
In the classic two-receptor model, this  second  level of recognition  would  require 
two  receptors, one  for self-MHC and  the  other  for the  non-MHC  antigen.  In  the 
altered-self model the polymorphic self-MHC structure plus the antigen must repre- 
sent  an  overlapping  collection  of antigens  that  cross-react  with  the  polymorphic 
structures of allogeneic cells and also presumably of xenogeneic MHC. 
How is the concept of two levels of MHC recognition carried out in reality? We do 
not know. It is possible that the distinction between class I and class II recognition is 
achieved at the repertoire level and that there is one T  cell repertoire for the allele- 
specific determinants of class I antigen and another for the allele-specific determinants 
of class II. In this case we would have to argue,  for example, that  the polyrnorphic 
variation of class I  in the mouse could be recognized by the class I  repertoire of the 
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FIG. 6.  Hypothetical model for the separate recognition of the invariant class determinants and 
the polymorphic variation (for discussion see text) of MHC. SWAIN, DUTTON,  SCHWAB, AND YAMAMOTO  727 
human.  It  seems  more likely that  the  recognition  of class  I  and  class  II is  clearly 
separated  from  the  recognition  of  the  MHC  polymorphism.  This  is  illustrated, 
conceptually, in Fig. 6.  In the figure the different components of the T  cell receptor 
and  the  MHC  molecule  are  indications  of a  separation  of functions  and  do  not 
necessarily  imply separate  domains  or  separate  gene  products.  In  the  figure  it  is 
suggested that recognition of the class epitope positions and restricts what the element 
recognizing the allele-specific epitope can react with. In this version of the model the 
only structure that the T  cell receptor can engage is that part of the MHC molecule 
that  carries  the  polymorphic  variation  and  hence  provides  an  explanation  of the 
restriction  of the  T  cell  repertoire  to  these  epitopes.  The  question  of whether  self- 
MHC plus X and allogeneic MHC are recognized by one recognition structure or two 
is not addressed by this model, although it is drawn in the single-recognition mode. 
The blocking of class I recognition by anti-Lyt-2 and anti-Leu-2a reagents and the 
blocking  of class  II recognition  by  anti-Leu-2b  suggests  the  possibility  that  these 
antigens are carried by or are spatially close to the class-recognizing structures (6,  12), 
but other possible explanations for the blocking data are also possible. The studies of 
Dialynas et al. (21), which show a strong correlation between loss of Lyt-2 expression 
and loss of non-lectin-mediated cytotoxicity in mutant cell lines, are also compatible 
with this concept. 
In summary, the specificity for the allele-specific determinants in the T cell response 
to  xenogeneic  lymphocytes on  the  one  hand,  coupled  with  the  ability  to  make a 
functional distinction between xenogeneic class I and class II structures on the other, 
argues  for a  model  in  which  these  two  components  of T  cell  recognition  involve 
separate interaction sites on the T  cell receptor. 
Summary 
Human  T  cells  respond  strongly  to  mouse  major  histocompatibility  complex 
(MHC)  antigens. The response is directed predominantly to the polymorphic deter- 
minants of the MHC antigens and there is little or no response to the nonpolymorphic 
determinants or to non-MHC antigens. Human cytotoxic T  lymphocytes (CTL) are 
generated  specific for the  mouse class  I  MHC  antigens  and  the  CTL effectors are 
blocked by anti-Leu-2a antisera. Human interleukin 2-producing T cells are generated 
specific  for mouse class  II antigens  and  their  induction  is  blocked  by anti-Leu-3a 
antisera.  These and other considerations  lead  us to propose a  model  for the T  cell 
receptor that provides an explanation for several of the features of T  cell recognition. 
In this model, the recognition of the "class" (I or II) of MHC antigen is separate from 
the recognition of the polymorphic determinants.  We suggest that the initial recog- 
nition of the conserved "class" determinants positions another domain of the receptor 
so  that  it  can  only  engage  with  the  part  of  the  MHC  molecule  carrying  the 
polymorphic determinants. 
We thank  Michele  English  and  Linda Walker for their excellent  technical  assistance,  and 
Kathy Wong for her secretarial assistance. 
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